We would like to inform you that the provision to revoke the marketing authorizations of PMC products intended for the disinfection of intact skin before medical treatment has been adopted. The official provision of March 29, 2023 aims to align the legislation with the European guidelines which categorize those products as pharmaceuticals.
The order provides:
- a general deadline for the revocation of the PMC authorizations of disinfectant products for intact skin before medical treatment, established on January 1, 2025, with the possibility of being able to make available on the market the batches already placed on the market until June 30, 2025; and
- specific terms for removal of products already authorized according to BPR
The provision is available at this link. For more information and support on biocides, do not hesitate to contact us.
